Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

The combined treatment for hair loss is effective, easy to use, and has mild side effects.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Genetic discoveries are leading to new treatments for alopecia areata.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Researchers found that certain RNA circles in the brain are linked to disease risk, but their exact role in disease is still unknown.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.